Cellosaurus A549-hACE2 [Invivogen] (CVCL_A5KA)
| Cell line name | A549-hACE2 [Invivogen] | |
|---|---|---|
| Accession | CVCL_A5KA | |
| Resource Identification Initiative | To cite this cell line use: A549-hACE2 [Invivogen] (RRID:CVCL_A5KA) | |
| Comments | Group: SARS-CoV-2 research cell line. Population: Caucasian. Characteristics: Permissive to infection by SARS-CoV-2 and/or spike-pseudotyped lentiviral particles (InvivoGen=a549-hace2). Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13557; ACE2. Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR). Derived from site: In situ; Lung; UBERON=UBERON_0002048. | |
| Sequence variations |
| |
| Disease | Lung adenocarcinoma (NCIt: C3512) | |
| Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) | |
| Hierarchy | Parent: CVCL_0023 (A-549) Children:
| |
| Sex of cell | Male | |
| Age at sampling | 58Y | |
| Category | Cancer cell line | |
| Cross-references | ||
| Cell line collections (Providers) | InvivoGen; a549-hace2 | |
| Cell line databases/resources | cancercelllines; CVCL_A5KA | |
| Encyclopedic resources | Wikidata; Q107113335 | |
| Entry history | ||
| Entry creation | 20-May-2021 | |
| Last entry update | 14-Aug-2025 | |
| Version number | 9 | |